Piper Sandler Maintains EDAP TMS(EDAP.US) With Buy Rating, Cuts Target Price to $5
H.C. Wainwright Maintains EDAP TMS(EDAP.US) With Buy Rating, Maintains Target Price $19
Edap TMS Analyst Ratings
H.C. Wainwright Maintains EDAP TMS(EDAP.US) With Buy Rating, Maintains Target Price $19
EDAP TMS: Strategic Growth and Diverse Revenue Streams Support Buy Rating
Lake Street Keeps Their Buy Rating on EDAP TMS (EDAP)
EDAP TMS Price Target Maintained With a $19.00/Share by HC Wainwright & Co.
Analysts' Opinions Are Mixed on These Healthcare Stocks: Apellis Pharmaceuticals (APLS) and EDAP TMS (EDAP)
Edap TMS Analyst Ratings
Buy Rating on EDAP TMS Maintained Despite Mixed Phase 3 Results, Highlighting Potential of HIFU for Endometriosis
Edap TMS Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN), Longeveron (LGVN) and EDAP TMS (EDAP)
Edap TMS Analyst Ratings
EDAP TMS (EDAP) Receives a Buy From Piper Sandler
Lake Street Reaffirms Their Buy Rating on EDAP TMS (EDAP)
Analysts Offer Insights on Healthcare Companies: Dynavax (DVAX) and EDAP TMS (EDAP)
Analysts' Top Healthcare Picks: EDAP TMS (EDAP), DermTech (DMTK)
Analysts Offer Insights on Healthcare Companies: Inspire Medical Systems (INSP) and EDAP TMS (EDAP)
Piper Sandler Maintains Overweight on Edap TMS, Lowers Price Target to $9-Report Released on 9th Nov 2023
Edap TMS Analyst Ratings